香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Haina Intelligent Equipment International Holdings Limited 海 納 智 能 裝 備 國 際 控 股 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：1645） 截至二零二二年十二月三十一日止年度之全年業績公告 財務摘要 • 截至二零二二年十二月三十一日止年度，本集團之總收益約為人民幣397.8百萬元（二 零二一年：約人民幣393.0百萬元），與截至二零二一年十二月三十一日止年度相比 增加約1%。 • 截至二零二二年十二月三十一日止年度，本集團之毛利約為人民幣64.2百萬元（二 零二一年：約人民幣84.8百萬元），與截至二零二一年十二月三十一日止年度相比 下降約24%。 • 截至二零二二年十二月三十一日止年度，本公司擁有人應佔虧損約為人民幣3.1百 萬元（二零二一年：本公司擁有人應佔溢利約人民幣27.0百萬元）。 • 截至二零二二年十二 ...

Financial Performance - Total revenue for the first half of 2022 was approximately RMB 199.8 million, with a total of 29 machines sold[10]. - The company recorded a net loss of approximately RMB 4.4 million during the same period[10]. - Revenue for the six months ended June 30 decreased by approximately RMB 1.4 million (or 1%) to about RMB 199.8 million, primarily due to declines in sales of baby diaper machines and female hygiene machines[22]. - Gross profit decreased by approximately RMB 13.7 million to about RMB 32.1 million, with a gross margin drop of about 6.7 percentage points to approximately 16.1%[23]. - The company reported a loss before tax of RMB 4,075 thousand, compared to a profit of RMB 19,921 thousand in 2021[83]. - Net loss for the period was RMB 4,401 thousand, a significant decline from a profit of RMB 17,732 thousand in the prior year[83]. - The company reported a comprehensive loss of RMB 4,885 thousand for the period, compared to a comprehensive income of RMB 18,163 thousand in the previous year[83]. - The basic loss per share attributable to the company's owners for the six months ended June 30, 2022, was RMB (4,335,000), compared to a profit of RMB 18,336,000 for the same period in 2021[131]. Research and Development - Research and development expenses for the period amounted to approximately RMB 14.07 million, fully funded by internal resources[13]. - A new research and development center will be established on a land area of approximately 28,353 square meters, costing RMB 19.90 million, to enhance production efficiency[9]. - The company is focused on enhancing its research and development capabilities through precision manufacturing and increased automation[13]. - Future strategies include improving research and development efficiency and production flexibility through acquisitions and new technologies[11][14]. - Research and development expenses for the six months ended June 30, 2022, were RMB 14,072 thousand, slightly down from RMB 14,746 thousand in the same period of 2021[123]. Market Expansion and Sales - The company plans to expand its market presence by selling products to 9 overseas countries during the reporting period[10]. - The company is enhancing its market penetration by increasing advertising efforts on major media platforms and collaborating with an agency for sales in South America[17]. - Sales of adult diapers increased significantly to RMB 118,985 thousand, up 92.5% from RMB 61,814 thousand in the previous year[118]. - The sales of baby diapers decreased to RMB 51,232 thousand, down 50.9% from RMB 104,232 thousand in the previous year[118]. - Major customer A contributed RMB 20,141 thousand, representing over 10% of total revenue for the period, while in the previous year, this customer contributed less than 10%[117]. Operational Efficiency - The company plans to invest at least RMB 600 million in a digital factory to enhance production efficiency and meet increasing market demand for disposable hygiene product automation machines[15]. - The company operates two production bases in China, with a total floor area of approximately 53,000 square meters[8]. - The company has successfully acquired land for a new R&D and production center with an investment of no less than RMB 350 million[15]. - The company is developing a "5G + Smart Equipment Operation and Maintenance Service Platform" in collaboration with China Telecom, aimed at transforming its business model and improving operational efficiency[18]. Financial Position and Liquidity - As of June 30, 2022, unutilized net proceeds from the share issuance amounted to approximately RMB 52.1 million, deposited in licensed banks in Hong Kong and China[35]. - The liquidity ratio as of June 30, 2022, was approximately 2.1 times, compared to 2.0 times on December 31, 2021, indicating stable operational funding from internal resources and interest-bearing borrowings[44]. - The group had bank loans of approximately RMB 30.0 million as of June 30, 2022, down from RMB 39.2 million as of December 31, 2021[47]. - The debt-to-equity ratio was approximately 15.2% as of June 30, 2022, compared to 19.1% as of December 31, 2021[50]. - The total cash and cash equivalents at the end of the reporting period were RMB 75,284,000, down from RMB 194,308,000 at the end of the previous year, reflecting a decrease in liquidity[98]. Employee and Management Costs - Employee costs for the period were approximately RMB 21.2 million, slightly up from RMB 21.0 million in the previous period[54]. - Total remuneration for key management personnel, including directors, was RMB 1,625,000 for the six months ended June 30, 2022, up from RMB 1,097,000 in 2021, representing a year-on-year increase of 48%[170]. - The group employed approximately 401 employees as of June 30, 2022, down from 413 employees a year earlier[54]. Share Capital and Dividends - The company has not declared an interim dividend for the period[31]. - The company issued shares during the period, raising RMB 68,666,000, with transaction costs of RMB (695,000)[89]. - The total issued and paid-up shares increased to 563,976,000, up from 470,004,000 on January 1, 2021, representing a growth of approximately 19.9%[156]. - The net proceeds from the share placement were allocated to enhance the company's equity base, with approximately HKD 81,851,000 recorded under share premium[156]. Legal and Compliance - The company recorded a provision for litigation claims of RMB 1,600,000 as of June 30, 2022, related to a civil lawsuit concerning product quality issues[149]. - The audit committee, consisting of three independent non-executive directors and one non-executive director, has reviewed the unaudited financial statements and believes they comply with applicable accounting standards[66].

Financial Performance - Haina Intelligent Equipment recorded total revenue of approximately RMB 393.0 million for the year, a decrease of about 17.1% compared to the previous year[7] - The company sold a total of 62 machines during the year, reflecting a decline in sales volume[7] - Net profit after tax was approximately RMB 26.3 million, down about 47.5% from the previous year, with earnings per share at RMB 0.0521[7] - The group recorded total revenue of approximately RMB 393.0 million for the year, with a total of 62 machines sold, representing a decrease of about 17.1% compared to the previous year[20] - The net profit after tax for the group was approximately RMB 26.3 million, a decrease of about 47.5% from the previous year[20] - The company's revenue decreased by approximately RMB 81.3 million (or 17.1%) to about RMB 393.0 million, primarily due to a reduction in sales of disposable medical mask machines by approximately RMB 164.8 million[33] - The gross profit for the year was approximately RMB 84.8 million, a decrease of about RMB 54.5 million from the previous year, resulting in a gross margin of approximately 21.6%, down from 29.4%[35] - The profit attributable to the owners of the company for the year was approximately RMB 27.0 million, a decrease from RMB 40.0 million in the previous year[42] Investments and Acquisitions - Haina Intelligent plans to establish a dedicated R&D center in Jinjiang, Fujian Province, to enhance product development efficiency[10] - The company completed the acquisition of the remaining 49% stake in Hangzhou Haina Machinery, making it a wholly-owned subsidiary[11] - The group has successfully acquired land use rights for approximately 27,594 square meters at a cost of about RMB 21.83 million for the construction of a digital factory[19] - The company signed a land reservation agreement on December 17, 2021, for approximately 40 acres of land at a total price of RMB 199 million to build a dedicated R&D center in Jinjiang[65] - The company entered into a share subscription agreement on July 28, 2021, to acquire 19.8% equity in an automation production and logistics technology solutions provider for HKD 19.8 million[63] - The group completed the acquisition of the remaining 49% stake in Hangzhou Haina Machinery, making it a wholly-owned subsidiary[24] Research and Development - Haina Intelligent holds 147 patents in China, emphasizing its strong R&D capabilities[8] - The group intends to continue increasing R&D investment, with R&D expenditures for the year amounting to approximately RMB 32.0 million[23] - The group aims to establish a dedicated R&D center in Jinjiang, Fujian Province, to improve R&D efficiency and reduce product development time[23] - The company is developing a "5G + Hygiene Industry Industrial Internet Digital Empowerment Platform" in collaboration with China Telecom, with the first phase of the big data dashboard completed and full completion expected within two years[30] Market Expansion - Haina Intelligent intends to invest in a digital factory to increase production capacity and meet higher market demands[12] - The company aims to expand its sales reach to 13 overseas countries while maintaining a strong presence in the domestic market[7] - The group has deepened its penetration in both domestic and overseas markets, gaining 12 new customers in China and 2 overseas[15] - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of the next fiscal year[136] Corporate Governance - The company is committed to maintaining high standards of corporate governance and has complied with the applicable corporate governance code[69] - The roles of the chairman and CEO are currently held by the same individual, which the board believes ensures effective leadership and decision-making[69] - The company has established three committees: the audit committee, the remuneration committee, and the nomination committee to assist the board in governance[85] - The audit committee is composed of three independent non-executive directors and one non-executive director, ensuring appropriate professional accounting qualifications[87] - The board consists of eight members with a balanced mix of experience in management, strategic development, quality assurance, risk management, and finance[99] Shareholder Information - The company has established a website for shareholders and investors to access the latest financial information, business developments, announcements, and contact details[119] - The total reserves available for distribution to shareholders as of December 31, 2021, amounted to approximately RMB 161.3 million, an increase from RMB 120.2 million in 2020[160] - The group did not recommend the payment of a final dividend for the reporting period[151] - The board retains discretion over any proposed dividend distribution, amount, and payment method, which will depend on various factors including actual and expected financial performance[121] Risk Management - The company has a clear internal control and risk management system in place, which was reviewed by the audit committee[88] - The company has established a three-tier risk management approach to identify, assess, and manage various types of risks[105] - The audit committee reviews the effectiveness of the risk management and internal control systems and provides recommendations to the board[104] Employee Information - Employee costs for the year were approximately RMB 46.9 million, an increase from RMB 38.9 million in the previous year[60] - All directors are encouraged to participate in ongoing professional development activities to ensure they remain informed and relevant[84] Financial Position - As of December 31, 2021, cash and bank balances were approximately RMB 102.4 million, down from RMB 230.4 million as of December 31, 2020[46] - The group's debt-to-equity ratio as of December 31, 2021, was approximately 19.1%, compared to 8.9% as of December 31, 2020[50] - The group had unutilized capital commitments of approximately RMB 29.2 million for the development of intangible assets and RMB 19.9 million for land use rights as of December 31, 2021[51]

Financial Performance - The company recorded revenue of approximately RMB 474.3 million for the year, representing a year-on-year increase of about 25.5%[7] - Profit attributable to owners of the company was approximately RMB 40 million, reflecting a year-on-year increase of about 51.2%[7] - The net profit after tax for the year was approximately RMB 50.1 million, which is an increase of about 61.2% compared to the previous year[7] - Total revenue for the year ended December 31, 2020, was approximately RMB 474.3 million, an increase of 25.4% compared to RMB 377.9 million in 2019[36] - Gross profit for the same period was RMB 139.3 million, resulting in a gross margin of 29.4%, up from 24.0% in 2019[26][36] - Net profit after tax was approximately RMB 50.1 million, representing a growth of 61.2% from RMB 31.1 million in the previous year[36] - Other income rose by approximately RMB 2.1 million or 25% to about RMB 10.5 million, primarily due to increased bank interest income from government subsidies and bank balances[55] - Selling and distribution costs increased by approximately RMB 1.3 million or 9% to about RMB 15.9 million, mainly due to commission and consulting fees[56] - Administrative and other operating expenses rose by approximately RMB 14.9 million or 40% to about RMB 51.8 million, driven by charitable donations and increased legal and professional fees[58] - Financial costs increased by approximately 30% to about RMB 1.3 million due to increased financial expenses related to lease liabilities and bank borrowings[61] - Income tax expenses rose by approximately 159% to about RMB 13.2 million, primarily due to increased profits from the company's Chinese operations[63] Production and Sales - The company sold a total of 282 machines during the year, with disposable medical mask machines accounting for approximately 34.7%, an increase of about 25.5% compared to the previous year[7] - The sales value of disposable hygiene product machines in China is projected to increase at an annual rate of approximately 6.5% from 2020 to 2024, reaching about RMB 12 billion by 2024[14] - The sales contribution from baby diaper machines, adult diaper machines, and women's sanitary napkin machines decreased from about 96% to approximately 61% of total revenue due to the shift in production capacity towards disposable medical mask machines[49] - The company has deepened its penetration in the Chinese market, acquiring 20 new customers for disposable hygiene product machines during the year[45] - The company has signed sales contracts for 43 baby diaper machines, 15 adult diaper machines, 18 feminine hygiene machines, and 3 pad machines, with a total contract value of approximately RMB 295.6 million, RMB 131.2 million, RMB 111.5 million, and RMB 7.5 million respectively as of December 31, 2020[53] Research and Development - The company holds 146 patents and continues to invest significant resources in R&D to enhance product development capabilities and quality[8] - Research and development expenses for the year amounted to approximately RMB 25.9 million, with RMB 19.1 million funded from internal resources[41] - The company plans to establish a dedicated research and development center in Jinjiang, Fujian Province, to enhance its R&D capabilities[40] - The company is committed to continuous innovation and development of high-tech intelligent products to maintain industry leadership[17] - The management team has emphasized the importance of R&D, allocating 15% of total revenue towards new technology development[148] Market Expansion and Strategy - The company aims to maintain its position as one of China's top suppliers of disposable hygiene product machinery through continuous R&D enhancement and market penetration[8] - The company plans to increase production capacity and competitiveness through acquisitions and expansion in both domestic and international markets[8] - The company plans to increase sales and marketing resources to penetrate overseas markets, particularly in Southeast Asia and India, following the easing of travel restrictions[14] - The company intends to explore opportunities in supplying disposable medical and hygiene products in both domestic and overseas markets[46] - The company is exploring market expansion opportunities in Southeast Asia, targeting a 10% market share within the next two years[148] Corporate Governance - The company has adopted corporate governance principles that align with the interests of the company and its shareholders[86] - The board of directors consists of 4 executive directors, 1 non-executive director, and 3 independent non-executive directors as of December 31, 2020[88] - The board has established three committees: Audit Committee, Remuneration Committee, and Nomination Committee to enhance corporate governance[104] - The Audit Committee, consisting of three independent non-executive directors, reviewed the annual financial statements and provided recommendations to the board[106] - The company has implemented internal controls and checks to define the responsibilities and authority of the board and management[98] Financial Position - Non-current assets decreased from RMB 46,269 thousand in 2019 to RMB 41,989 thousand in 2020, while current assets increased significantly from RMB 290,270 thousand to RMB 515,308 thousand[20] - The company's net asset value rose from RMB 113,271 thousand in 2019 to RMB 279,998 thousand in 2020, indicating strong financial growth[20] - The current ratio improved to 2.0 in 2020, compared to 1.4 in 2019, indicating better short-term financial health[31] - The interest coverage ratio was 50.2 times in 2020, reflecting strong earnings relative to interest expenses[35] - The bank and cash balance as of December 31, 2020, was approximately RMB 230.4 million, an increase of about RMB 194.7 million from RMB 35.7 million as of December 31, 2019[66] Dividend and Shareholder Returns - The board proposed a final dividend of HKD 0.05 per share for the year ended December 31, 2020[7] - The proposed final dividend is HKD 0.05 per share, amounting to approximately HKD 23.5 million (around RMB 20.9 million), with no dividends declared in 2019[177] - The company does not have a fixed dividend policy, but the board expects the dividend payout ratio to be no less than 25% of the annual distributable profit[138] - The board retains discretion over any proposed dividend distribution, amount, and payment method, which will depend on various factors including actual and expected financial performance[138] Social Responsibility - The group made charitable donations of approximately RMB 2.4 million during the reporting period, compared to none in 2019[178] - The company has committed to sustainable development and compliance with environmental protection laws and regulations[176]

Financial Performance - The total revenue for the period was approximately RMB 207.9 million, with a total of 210 machines sold, of which around 96% were disposable medical mask machines[9]. - The net profit after tax for the period was approximately RMB 32.4 million, representing a growth of about 17.9%[9]. - The company's revenue increased by approximately RMB 31.4 million (or 18%) to about RMB 207.9 million for the six months ended June 30, 2020, compared to approximately RMB 176.4 million for the same period in 2019[22]. - The gross profit increased by approximately RMB 35.1 million, with a gross profit margin rising to about 38% from approximately 25% in the previous period[27]. - The company reported a profit of RMB 24,603,000, compared to RMB 11,600,000 for the same period in 2019, representing an increase of 112.9%[84]. - The net profit for the six months ended June 30, 2020, was RMB 32,412,000, up from RMB 13,998,000 in 2019, reflecting a year-on-year growth of 131.5%[78]. - Basic and diluted earnings per share increased to RMB 6.73 from RMB 2.46, indicating strong profitability growth[78]. - The company reported a comprehensive income of RMB 22,951,000 for the six months ended June 30, 2020, compared to RMB 30,760,000 for the same period in 2019, indicating a decrease of 25.7%[88]. Revenue Breakdown - The sales value of disposable hygiene product machines in China is expected to increase at an annual rate of approximately 6.5% from 2020 to 2024, reaching about RMB 12 billion by 2024[18]. - The sales of disposable medical mask machines contributed approximately RMB 144.7 million to the revenue, with 201 units sold during the period[23]. - Revenue from the sale of disposable medical masks was RMB 144,734 thousand, which was not reported in the previous year[116]. - Revenue from the sale of adult diapers decreased to RMB 11,212 thousand from RMB 63,710 thousand in the prior year, representing a decline of 82.4%[116]. - Revenue from the sale of baby diapers decreased to RMB 44,832 thousand from RMB 104,136 thousand in the prior year, a decline of 56.9%[116]. Research and Development - The company plans to establish a dedicated R&D center in Jinjiang, Fujian Province, to enhance its R&D capabilities and improve product development efficiency[11]. - R&D expenses for the period were approximately RMB 9.4 million, funded by the company's internal resources[13]. - The company currently holds 127 patents in China, reflecting its strong commitment to R&D and technological advancement[9]. - The company aims to acquire a company engaged in the development, design, and manufacturing of automated packaging equipment to enhance its competitive edge[14]. Market Strategy - The company is focused on increasing its market penetration in both domestic and overseas markets to maintain its position as a leading supplier of disposable hygiene product machinery in China[10]. - The company plans to deepen its penetration in the disposable hygiene product machine industry in China and expand into overseas markets such as Southeast Asia and India[21]. - The company aims to increase sales and marketing resources to promote its products and enhance R&D efforts to cater to different overseas market preferences[21]. Operational Capacity - The company intends to increase production capacity by renting an additional 10,000 square meters of production property in Jinjiang, which will accommodate five new production lines[16]. - The company has two production bases in China, with a total floor area of approximately 35,400 square meters, operating 16 production lines in Jinjiang and 6 in Hangzhou[8]. - The company has established sales contracts for 34 baby diaper machines, 15 adult diaper machines, and 6 disposable medical mask machines, with total contract values of approximately RMB 213.6 million, RMB 144.3 million, and RMB 4.7 million, respectively[26]. Financial Position - As of June 30, 2020, the current ratio was approximately 2.35, up from 1.44 as of December 31, 2019, indicating improved liquidity[43]. - The company's capital structure included equity of approximately RMB 282.0 million as of June 30, 2020, compared to RMB 113.3 million as of December 31, 2019[45]. - The company had no outstanding bank borrowings as of June 30, 2020, confirming no liquidity issues[46]. - The unutilized proceeds from the share offering amounted to approximately RMB 119.4 million, held in licensed banks in Hong Kong and China[42]. - The company’s total equity reached RMB 282,001,000 as of June 30, 2020, compared to RMB 113,271,000 at the end of 2019, reflecting a substantial increase in shareholder value[82]. Employee and Administrative Costs - As of June 30, 2020, the group employed approximately 389 employees, an increase from 362 employees as of June 30, 2019[52]. - Employee costs, including director remuneration, amounted to approximately RMB 18.2 million, compared to RMB 15.8 million in the previous period, reflecting an increase of about 15.2%[52]. - Administrative and other operating expenses increased by approximately RMB 1.9 million or 10.2% to about RMB 20.6 million, mainly due to charitable donations of RMB 2.4 million[31]. Share Capital and Financing - The total issued share capital increased to 2,000,000,000 shares with a par value of HKD 0.01 per share as of June 30, 2020[159]. - The company completed a capitalized issuance of 347,999,990 shares, raising approximately RMB 3,195,000[164]. - The company issued 116,000,000 shares at an exercise price of HKD 1.38 per share on June 3, 2020, as part of a share sale[164]. - The total expenses related to the share sale and over-allotment amounted to approximately RMB 29,153,000[165]. Tax and Financial Costs - Income tax expenses increased by approximately 299% to about RMB 9.2 million, attributed to increased taxable profits from operating subsidiaries[34]. - Financial costs increased by approximately 71% to about RMB 0.7 million, primarily due to increased financial expenses related to lease liabilities[33]. - The company reported a significant increase in current tax expenses to RMB 9,240,000 from RMB 2,639,000, an increase of 250%[129]. Compliance and Governance - The company has not engaged in any share buybacks or sales during the reporting period, except for the issuance of shares related to the over-allotment option[65]. - The chairman and CEO roles are held by the same individual, which the board believes ensures effective leadership and decision-making[59]. - The company has no other disclosures required under the listing rules apart from those mentioned, indicating compliance with regulatory requirements[76].